Genentech, Inc.South San Francisco, CA, United States (NYSE: DNA)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Genentech Financial Statements

Genentech Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Genentech Income Statement

  2007 2006 2005
Revenue ($ mil.) 11,724.0 9,284.0 6,633.4
Gross Profit ($ mil.) 10,153.0 8,103.0 5,622.3
Operating Income ($ mil.) 4,229.0 3,152.0 1,921.8
Total Net Income ($ mil.) 2,769.0 2,113.0 1,279.0
Diluted EPS (Net Income) 2.59 1.97 1.18
More Genentech financial information

Genentech Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 3,236.0 3,063.0 2,969.0
Gross Profit ($ mil.) 2,794.0 2,674.0 2,625.0
Operating Income ($ mil.) 1,229.0 1,519.0 985.0
Total Net Income ($ mil.) 781.0 983.0 631.0
Diluted EPS (Net Income) 0.73 0.92 0.59
More Genentech financial information

Genentech Stock Quote & Chart

09/05/08 11:47:13 EST • NYSE • 96.25 • Decreased by -0.2500 • Decreased by -0.2591 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Genentech Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 8.49 3.44 1.55
Price/Earnings Ratio 33.41 15.44 15.69
Price/Book Ratio 7.78 2.92 1.50
Price/Cash Flow Ratio 34.35 12.54 9.64
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Genentech Financial Ratios

Genentech Competitive Intelligence

Amgen Bristol-Myers Squibb GlaxoSmithKline
Annual Sales ($ mil.) 14,771.0 19,348.0 37,272.5
Employees 17,500 42,000 100,728
Market Cap ($ mil.) 67,732.6 43,230.6 --

Competitive Landscape